These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15157268)

  • 1. Late-onset pure red blood cell aplasia owing to delayed lymphoid engraftment complicating ABO-mismatched hematopoietic stem cell transplantation.
    Au WY; Lie AK; Ma ES; Lau GK; Chan EC; Kwong YL
    Transfusion; 2004 Jun; 44(6):946-7. PubMed ID: 15157268
    [No Abstract]   [Full Text] [Related]  

  • 2. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
    Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
    Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
    Furuya H; Wakayama T; Tanaka J; Tsumori M; Hatazoe T; Ohguni S; Sato T; Ishikura H; Kato Y
    Rinsho Ketsueki; 1995 Nov; 36(11):1279-83. PubMed ID: 8691568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
    Huang T; Sun J; Liu J; Liu QF; Men FY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.
    Benjamin RJ; Connors JM; McGurk S; Churchill WH; Antin JH
    Biol Blood Marrow Transplant; 1998; 4(3):151-6. PubMed ID: 9923413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation.
    Zhidong W; Hongmin Y; Hengxiang W
    Transfus Med; 2012 Aug; 22(4):302-4. PubMed ID: 22540210
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
    Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
    Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ABO-incompatible allogeneic bone marrow transplantation].
    Xu L; Guo N; Wang S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
    Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation.
    Ohta S; Yokoyama H; Ise T; Takasawa K; Wada T; Nakao S; Matsuda T; Kobayashi K
    Intern Med; 1997 Jul; 36(7):487-91. PubMed ID: 9240498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
    Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
    Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.
    Roychowdhury DF; Linker CA
    Bone Marrow Transplant; 1995 Sep; 16(3):471-2. PubMed ID: 8535322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
    Yamaguchi M; Sakai K; Murata R; Ueda M
    Bone Marrow Transplant; 2002 Oct; 30(8):539-41. PubMed ID: 12379896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
    Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
    Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.